LATS2 and esophageal squamous cell carcinoma: In conclusion, LATS2 may be related to the occurrence, development, and prognosis of ESCC, and LATS2 may play an important role in the immune infiltration of ESCC, which provides potential value for the role of LATS2 in immunotherapy of ESCC.